3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
68
Colonic Neoplasms
22
Rectal Neoplasms
21
Neoplasm Metastasis
18
Neoplasms
15
Carcinoma, Non-Small-Cell Lung
8
Head and Neck Neoplasms
7
Esophageal Neoplasms
6
Cholangiocarcinoma
6
Lung Neoplasms
5
Carcinoma, Squamous Cell
5
Carcinoma
5
Squamous Cell Carcinoma of Head and Neck
4
Prostatic Neoplasms
4
Pancreatic Neoplasms
4
Breast Neoplasms
4
Stomach Neoplasms
2
Solid Tumors
2
Recurrence
2
Kidney Neoplasms
2
Gastrointestinal Neoplasms
2
Biliary Tract Neoplasms
2
Adenocarcinoma Of Esophagus
2
Adenocarcinoma
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Triple Negative Breast Neoplasms
1
Solid Tumor, Adult
1
Ovarian Neoplasms
1
Inflammatory Breast Neoplasms
1
Gallbladder Neoplasms
1
Interventions
Gemcitabine
34
Cisplatin
21
Capecitabine
18
Oxaliplatin
15
Leucovorin
10
Fluorouracil
10
Irinotecan
8
Erlotinib Hydrochloride
7
pembrolizumab
5
Bevacizumab
5
Radiotherapy
4
Carboplatin
4
Albumin-Bound Paclitaxel
4
130-nm albumin-bound paclitaxel
4
Watchful Waiting
3
Taxes
3
Sorafenib
3
Platinum
3
Interleukin-12 Subunit p35
3
Immunohistochemistry
3
Docetaxel
3
1,2-diaminocyclohexaneplatinum II citrate
3
trifluridine tipiracil drug combination
2
tremelimumab
2
regorafenib
2
durvalumab
2
dehydroftorafur
2
Trastuzumab
2
Paclitaxel
2
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Gallbladder Neoplasms
×
Panitumumab
×
Clear all
NCT01308840
2016-08-17
UGIH09067
University of Rochester
Phase 2
Completed
31 enrolled
10 charts